This is a notice of intent for a sole-source, one-year contract to maintain and support the existing Fuji Medical SynapseVNA product, which is the core of the NIH’s ResearchPACS system. The contract period is from September 4, 2026, to September 3, 2027. Fuji Medical is identified as the only entity capable of providing the required technical updates and support. The acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures, citing only one source as reasonably available. Performance of services is for the NIH Clinical Center.